[18] A 2019 study used liver function tests (serum, total bilirubin, alkaline phosphatase, alanine aminotransferase, gamma-glutamyl transferase, lactate dehydrogenase, and aspartate aminotransferase) and clinical observation of any adverse events to evaluate the safety of IV infusion of NAD+ in a cohort of healthy male participants (n=11
For example, in a 2009 pilot evaluation of intravenous glutathione therapy for individuals with Parkinsons disease at the University of South Florida, researchers reported that glutathione IV therapy that mildly benefited motor symptoms was well tolerated and posed no safety concerns. A 2017 case report yielded similar results
When treatments like microneedling or RFMN create microchannels in the skin, this barrier is intentionally disrupted to stimulate healing
Each vial contains a single compound with no fillers, blends, or diluted concentrations